Speakers: Sebastian Rausch, PhD & Gopal Swamy Jayabalan, PhD, Heidelberg Engineering, Germany
Location: OPT 350
Fluorescence lifetime imaging ophthalmoscopy (FLIO) is a new imaging technology that has the potential to measure differences attributable to biochemical and environmental changes in retinal fluorophores, independent of autofluorescence accumulation. The ocular fluorescence lifetime pattern across the macula varies in the healthy eye as a function of age and in many diseases including AMD, choroideremia, Alzheimer’s disease, and diabetes. Heidelberg Engineering has developed a clinical system to perform FLIO in the living eye. With only 13 devices worldwide, we are excited to have acquired one of these new instruments at Waterloo. This is synergistic with recent developments in cellular-scale fluorescence adaptive optics ophthalmoscopy. Please join us to learn about this new cutting-edge technology.
FLIO in the anterior segment
